AUTEN-67 is an autophagy-enhancing drug candidate that increases autophagic flux in cell lines and in vivo models. It hampers the progression of neurodegenerative…
AUTEN-67 is an autophagy-enhancing drug candidate that increases autophagic flux in cell lines and in vivo models.
It hampers the progression of neurodegenerative symptoms in a Drosophila model of Huntington's disease. It is developed by Velgene Biotechnology Ltd.
References
Gebaseerd op: Wikipedia — AUTEN-67 · auteursgeschiedenis.
Tekst: CC BY-SA 4.0.
Wikisyntaxis en sjablonen zijn verwijderd; langere teksten zijn ingekort.